- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
C
HELP
Cybin Inc
7.68
-0.05-0.65%Opening11:45 01/06 EST
OPEN/PREV CLOSE7.62/7.73
TODAY RANGE7.50-8.03
VOL364.73K
MARKET CAP383.19M
52 WEEK RANGE4.810-10.73
AVG VOL (3M)878.01K
% TURNOVER0.73%
TURNOVER--
P/E (TTM)-2.3846
% RANGE6.82%
EPS(TTM)-3.2206
P/E(FORWARD)-2.4809
P/B2.007
BVPS3.826
DIVIDEND--
P/S46.38
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP314.91M
SHARES OUTSTANDING49.89M
NEXT EARNINGS02/09-02/24
FREE FLOAT41.00M
LOT SIZE1
EX-DATE09/19/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·4d ago
Cybin 2026 Outlook: Clinical Milestones And Cash Position Set Stage For Momentum
TipRanks·12/31/2025 20:27
Cybin Launches US$100 Million At-the-Market Equity Program
Seeking Alpha·12/31/2025 14:48
Cybin initiates at-the-market equity program of up to $100 million
Benzinga·12/31/2025 13:26
Cybin, Xpeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga·12/31/2025 11:14
Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Seeking Alpha·12/31/2025 10:14
Biggest stock movers Wednesday: Vanda Pharmaceuticals and Cybin
TipRanks·12/30/2025 21:42
Cybin Sets Up US$100 Million At-the-Market Equity Program With Cantor Fitzgerald
TipRanks·12/30/2025 20:40
Cybin initiates at-the-market equity program of up to $100M
Benzinga·12/30/2025 20:36
Cybin Launches $100M At-The-Market Equity Program With Cantor Fitzgerald
Reuters·12/30/2025 20:33
CYBIN INITIATES AT-THE-MARKET EQUITY PROGRAM OF UP TO US$100 MILLION
TipRanks·12/22/2025 22:24
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq in Early January
TipRanks·12/22/2025 11:36
Cybin (CYBN) Receives a Buy from H.C. Wainwright
TipRanks·12/20/2025 02:07
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq
Reuters·12/19/2025 23:48
Cybin to Transfer U.S. Listing to Nasdaq and Rebrand as Helus Pharma in January 2026
Same Industry
Name/Symbol
Change%
Price